by MM360 Staff | May 19, 2025 | Myeloma News
Source: Pharmacy Times articles COVID-19 can reshape one’s academic journey and outlook on life. Read More
by MM360 Staff | May 19, 2025 | Myeloma News
Source: Pharmacy Times articles Pharmacists should continue to emphasize the vaccine’s effectiveness in preventing cancer and be prepared to address patient safety concerns. Read More
by MM360 Staff | May 19, 2025 | Myeloma News
Source: Pharmacy Times articles A study reveals sasanlimab enhances event-free survival in high-risk bladder cancer patients, offering new hope against disease recurrence. Read More
by MM360 Staff | May 19, 2025 | Myeloma News
Source: Pharmacy Times articles Patients should understand that routine skin care is an important facet in the overall management of diabetes. Read More
by MM360 Staff | May 19, 2025 | Myeloma News
Source: Pharmacy Times articles The vaccine, indicated with a restriction on use for those younger than 65 years and without comorbidities, was proven safe and effective in a series of large clinical trials, and marks the first protein-based vaccine to be approved in...
by MM360 Staff | May 19, 2025 | Myeloma News
Source: Pharmacy Times articles Panelists discuss how medical professionals consider PCSK9 inhibitors, bempedoic acid, and inclisiran in various clinical scenarios, their experiences with these newer therapies, the implications of the INCEPTION trial for treating...
